The junior high school girl’s death in July was the first fatality reported in Japan upon taking Cervarix.
However, the ministry said that it is not possible to recognize the pharmaceutical made by Britain’s GlaxoSmithKline P.L.C. as being directly responsible for her death.
A ministry report said the girl received a vaccine shot on July 28 and was found with her heart stopped and confirmed dead on July 30. The girl had a history of heart disease and it is believed the precise cause of her death stemmed from an irregular heartbeat.
Cervarix was first approved for use in Australia in May 2007 and went on sale in Japan from December 2009. An estimated 2.48 million women in Japan have been vaccinated against cervical cancer by using the drug.
The girl’s death soon after using Cervarix is the fifth such case reported around the world. None of these cases has directly linked the drug to causing death.